APOA5 and metabolic syndrome: 4) Lipid metabolism: The network regulators APOA5 and AFM control triglyceride-rich lipoprotein metabolism and oxidative stress41,53,54, are bio-druggable (Supplementary Data 16), and could be targeted to prevent dyslipidemia-driven initiation of atherosclerosis.